| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 16 |
| 1 | ASPIRIN | 13 |
| 2 | ASPIRIN 325 MG | 13 |
| 3 | ASPIRIN 81 MG | 13 |
| 4 | DIAZEPAM ORAL | 13 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 13 |
| 6 | PREDNISONE | 12 |
| 7 | FINGOLIMOD HCL | 11 |
| 8 | ALENDRONATE SODIUM | 10 |
| 9 | LEVOTHYROXINE SODIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMIDENEPAG ISOPROPYL | 3 | 0.0455 |
| 1 | PROPARACAINE HYDROCHLORIDE | 3 | 0.0056 |
| 2 | NETARSUDIL | 8 | 0.0041 |
| 3 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 3 | 0.0031 |
| 4 | BUTORPHANOL TARTRATE | 1 | 0.0030 |
| 5 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 6 | SODIUM HYALURONATE | 2 | 0.0024 |
| 7 | BELANTAMAB MAFODOTIN | 6 | 0.0019 |
| 8 | TROPICAMIDE | 3 | 0.0018 |
| 9 | FLUNISOLIDE | 2 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Benzodiazepine [EPC] | 25 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 5 | Prostaglandin Analog [EPC] | 13 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 |
| 7 | Vitamin C [EPC] | 11 |
| 8 | Proton Pump Inhibitor [EPC] | 10 |
| 9 | Anti-epileptic Agent [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Calcitonin [EPC] | 1 | 0.0003 |
| 3 | Anticholinergic [EPC] | 5 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 5 | 0.0002 |
| 7 | Antiseptic [EPC] | 1 | 0.0002 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |